vs
CENTERSPACE（CSR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是CENTERSPACE的1.1倍（$75.5M vs $66.6M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 0.3%），CENTERSPACE自由现金流更多（$64.3M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 1.6%）
Centerspace是一家专注于多户住宅物业持有、运营与开发的房地产投资企业，核心业务覆盖美国中西部及落基山西部区域，面向不同租户群体提供经济型及高端住宅选择，重视租户体验与资产长期价值增长。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CSR vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$66.6M
营收增速更快
PBYI
高出27.4%
0.3%
自由现金流更多
CSR
多$49.9M
$14.4M
两年增速更快
PBYI
近两年复合增速
1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.6M | $75.5M |
| 净利润 | $-18.4M | — |
| 毛利率 | 96.5% | 69.3% |
| 营业利润率 | -15.9% | 22.7% |
| 净利率 | -27.7% | — |
| 营收同比 | 0.3% | 27.7% |
| 净利润同比 | -262.9% | — |
| 每股收益（稀释后） | $-1.08 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSRPBYI
| Q4 25 | $66.6M | $75.5M | ||
| Q3 25 | $71.4M | $54.5M | ||
| Q2 25 | $68.5M | $52.4M | ||
| Q1 25 | $67.1M | $46.0M | ||
| Q4 24 | $66.4M | $59.1M | ||
| Q3 24 | $65.0M | $80.5M | ||
| Q2 24 | $65.0M | $47.1M | ||
| Q1 24 | $64.5M | $43.8M |
净利润CSRPBYI
| Q4 25 | $-18.4M | — | ||
| Q3 25 | $53.8M | $8.8M | ||
| Q2 25 | $-14.5M | $5.9M | ||
| Q1 25 | $-3.7M | $3.0M | ||
| Q4 24 | $-5.1M | — | ||
| Q3 24 | $-1.0M | $20.3M | ||
| Q2 24 | $-1.3M | $-4.5M | ||
| Q1 24 | $-3.9M | $-4.8M |
毛利率CSRPBYI
| Q4 25 | 96.5% | 69.3% | ||
| Q3 25 | 96.5% | 77.7% | ||
| Q2 25 | 96.5% | 76.5% | ||
| Q1 25 | 96.4% | 77.1% | ||
| Q4 24 | 96.5% | 76.4% | ||
| Q3 24 | 96.6% | 63.9% | ||
| Q2 24 | 96.6% | 77.4% | ||
| Q1 24 | 96.4% | 75.5% |
营业利润率CSRPBYI
| Q4 25 | -15.9% | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | -9.9% | 12.7% | ||
| Q1 25 | 7.1% | 8.7% | ||
| Q4 24 | 4.3% | 22.6% | ||
| Q3 24 | 9.8% | 27.4% | ||
| Q2 24 | 11.1% | -4.6% | ||
| Q1 24 | 6.3% | -5.3% |
净利率CSRPBYI
| Q4 25 | -27.7% | — | ||
| Q3 25 | 75.3% | 16.2% | ||
| Q2 25 | -21.2% | 11.2% | ||
| Q1 25 | -5.6% | 6.5% | ||
| Q4 24 | -7.6% | — | ||
| Q3 24 | -1.6% | 25.2% | ||
| Q2 24 | -2.0% | -9.6% | ||
| Q1 24 | -6.1% | -11.0% |
每股收益（稀释后）CSRPBYI
| Q4 25 | $-1.08 | $0.26 | ||
| Q3 25 | $3.19 | $0.17 | ||
| Q2 25 | $-0.87 | $0.12 | ||
| Q1 25 | $-0.22 | $0.06 | ||
| Q4 24 | $-0.31 | $0.40 | ||
| Q3 24 | $-0.40 | $0.41 | ||
| Q2 24 | $-0.19 | $-0.09 | ||
| Q1 24 | $-0.37 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.8M | $97.5M |
| 总债务越低越好 | $1.0B | $22.7M |
| 股东权益账面价值 | $719.2M | $130.3M |
| 总资产 | $1.9B | $216.3M |
| 负债/权益比越低杠杆越低 | 1.42× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CSRPBYI
| Q4 25 | $12.8M | $97.5M | ||
| Q3 25 | $12.9M | $94.4M | ||
| Q2 25 | $12.4M | $96.0M | ||
| Q1 25 | $11.9M | $93.2M | ||
| Q4 24 | $12.0M | $101.0M | ||
| Q3 24 | $14.5M | $96.7M | ||
| Q2 24 | $14.3M | $96.8M | ||
| Q1 24 | $12.7M | $107.2M |
总债务CSRPBYI
| Q4 25 | $1.0B | $22.7M | ||
| Q3 25 | $1.1B | $34.0M | ||
| Q2 25 | $1.1B | $45.3M | ||
| Q1 25 | $955.5M | $56.7M | ||
| Q4 24 | $955.4M | $68.0M | ||
| Q3 24 | $921.3M | $79.3M | ||
| Q2 24 | $931.7M | $90.7M | ||
| Q1 24 | $929.1M | $102.0M |
股东权益CSRPBYI
| Q4 25 | $719.2M | $130.3M | ||
| Q3 25 | $748.6M | $115.3M | ||
| Q2 25 | $710.1M | $104.7M | ||
| Q1 25 | $636.8M | $97.1M | ||
| Q4 24 | $752.0M | $92.1M | ||
| Q3 24 | $672.5M | $71.1M | ||
| Q2 24 | $680.7M | $48.5M | ||
| Q1 24 | $688.1M | $51.0M |
总资产CSRPBYI
| Q4 25 | $1.9B | $216.3M | ||
| Q3 25 | $2.1B | $202.9M | ||
| Q2 25 | $2.0B | $194.9M | ||
| Q1 25 | $1.9B | $196.2M | ||
| Q4 24 | $1.9B | $213.3M | ||
| Q3 24 | $1.9B | $220.7M | ||
| Q2 24 | $1.9B | $205.0M | ||
| Q1 24 | $1.9B | $214.1M |
负债/权益比CSRPBYI
| Q4 25 | 1.42× | 0.17× | ||
| Q3 25 | 1.53× | 0.30× | ||
| Q2 25 | 1.57× | 0.43× | ||
| Q1 25 | 1.50× | 0.58× | ||
| Q4 24 | 1.27× | 0.74× | ||
| Q3 24 | 1.37× | 1.12× | ||
| Q2 24 | 1.37× | 1.87× | ||
| Q1 24 | 1.35× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $64.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 96.5% | 19.1% |
| 资本支出强度资本支出/营收 | 51.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $125.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CSRPBYI
| Q4 25 | $98.5M | $14.4M | ||
| Q3 25 | $35.1M | $9.7M | ||
| Q2 25 | $25.3M | $14.1M | ||
| Q1 25 | $25.4M | $3.6M | ||
| Q4 24 | $98.2M | $15.6M | ||
| Q3 24 | $32.3M | $11.0M | ||
| Q2 24 | $22.9M | $1.0M | ||
| Q1 24 | $24.4M | $11.2M |
自由现金流CSRPBYI
| Q4 25 | $64.3M | $14.4M | ||
| Q3 25 | $25.7M | $9.7M | ||
| Q2 25 | $15.5M | $14.1M | ||
| Q1 25 | $20.4M | $3.6M | ||
| Q4 24 | $41.6M | $15.6M | ||
| Q3 24 | $20.5M | $11.0M | ||
| Q2 24 | $9.1M | $1.0M | ||
| Q1 24 | $2.6M | — |
自由现金流率CSRPBYI
| Q4 25 | 96.5% | 19.1% | ||
| Q3 25 | 36.0% | 17.7% | ||
| Q2 25 | 22.7% | 26.8% | ||
| Q1 25 | 30.4% | 7.7% | ||
| Q4 24 | 62.6% | 26.4% | ||
| Q3 24 | 31.5% | 13.7% | ||
| Q2 24 | 14.0% | 2.1% | ||
| Q1 24 | 4.0% | — |
资本支出强度CSRPBYI
| Q4 25 | 51.3% | 0.0% | ||
| Q3 25 | 13.1% | 0.0% | ||
| Q2 25 | 14.2% | 0.0% | ||
| Q1 25 | 7.5% | 0.1% | ||
| Q4 24 | 85.3% | 0.0% | ||
| Q3 24 | 18.2% | 0.0% | ||
| Q2 24 | 21.2% | 0.0% | ||
| Q1 24 | 33.8% | 0.0% |
现金转化率CSRPBYI
| Q4 25 | — | — | ||
| Q3 25 | 0.65× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSR
| Multi Family Residential | $57.3M | 86% |
| Other | $8.1M | 12% |
| Other Property Revenue | $1.2M | 2% |
PBYI
暂无分部数据
